Treatment Guidance

What does the Primary Care Dermatology Society say about the treatment of plaque psoriasis in primary care?

The Primary Care Dermatology Society (PCDS) has created a treatment pathway to support GPs and GPSIs in dermatology. It states:2,3

” A combination product is often considered a first line option for chronic plaque psoriasis on the body as an effective and cosmetically acceptable therapy. 

” Many GPs and GPSIs use calcipotriol and betamethasone combination products first line… in chronic plaque psoriasis…

* This statement differs from the NICE guidelines, which state: “offer a potent corticosteroid applied once daily plus vitamin D or a vitamin D analogue applied once daily (applied separately, one in the morning and the other in the evening) for up to 4 weeks as initial treatment for adults with trunk or limb psoriasis.SIGN guidelines list short-term intermittent use of a potent topical corticosteroid or a combined potent corticosteroid plus calcipotriol ointment for rapid improvement in plaque psoriasis.5

What do primary care experts in dermatology say about the guidelines for plaque psoriasis?

Enstilar® is a combination product containing calcipotriol and betamethasone dipropionate in a foam spray formulation

As a combination product, Enstilar® tackles both aspects of psoriasis.1

Diagram showing aspects of plaque psoriasis
For illustrative purposes only. Image from a representative psoriasis patient from the PSO-FAST study (DoF LEO90100 – 003 MAR 2016)6

See how Enstilar®’s efficacy compares to its individual components
GP: General Practitioner; GPSI: General Practitioner with Special Interest; NICE: National Institute for Health and Care Excellence; SIGN: Scottish Intercollegiate Guidelines Network.
  1. McCormack PL. Drugs 2011;71(6):709–730.
  2. Primary Care Dermatology Society. Psoriasis: an overview and chronic plaque psoriasis. Available at: Last accessed April 2019.
  3. Primary Care Dermatology Society. Psoriasis – primary care treatment pathway. Available at: Last accessed April 2019.
  4. National Institute for Health and Care Excellence (NICE). Psoriasis: assessment and management. Clinical guideline (CG)153. Available at: Last accessed April 2019.
  5. Scottish Intercollegiate Guidelines Network (SIGN). Diagnosis and management of psoriasis and psoriatic arthritis in adults Available at: Last accessed April 2019.
  6. Data on File: LEO90100 – 003 MAR 2016.
MAT-25297 August 2019

Keep in touch with LEO Pharma

Latest product information, consultation tools, hot topics in dermatology and congress updates.  Be the first to know with LEO Pharma. Sign up

MAT-29941 November 2019

Holler Box